Genzyme, Impax begin Revela patent fight
Genzyme sued Impax Laboratories for patent infringement after Impax filed for FDA approval of a copycat version of the kidney dialysis drug Renvela. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What's your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- Recipharm secures financing for future growth
- PPD Names David Simmons Chairman and CEO
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- PPD Names David Simmons Chairman and CEO
- NICE recommends new treatment option for people with common heart condition
- More Press Releases
Featured Jobs
-
Director, Human Resources
TESARO - Waltham, MA -
Sr. Director, Statistics Job
Celgene Corporation - Summit, NJ, US -
Senior Scientist - Permanent Job
Yoh - Doylestown, PA, USA -
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US -
Senior Manager, Global Market Insights Job
Celgene Corporation - Summit, NJ, US
Comments